1.
J Dtsch Dermatol Ges
; 22(5): 704-706, 2024 May.
Article
De
| MEDLINE
| ID: mdl-38730513
Antibodies, Monoclonal, Humanized , Azetidines , Purines , Pyrazoles , Sulfonamides , Female , Humans , Middle Aged , Antibodies, Monoclonal, Humanized/therapeutic use , Antibodies, Monoclonal, Humanized/adverse effects , Azetidines/therapeutic use , Drug Eruptions/etiology , Drug Eruptions/drug therapy , Facial Dermatoses/drug therapy , Neck/pathology , Purines/therapeutic use , Pyrazoles/therapeutic use , Sulfonamides/therapeutic use , Treatment Outcome
2.
J Dtsch Dermatol Ges
; 22(5): 704-705, 2024 May.
Article
En
| MEDLINE
| ID: mdl-38470157
Antibodies, Monoclonal, Humanized , Azetidines , Purines , Pyrazoles , Sulfonamides , Humans , Sulfonamides/therapeutic use , Sulfonamides/adverse effects , Pyrazoles/adverse effects , Pyrazoles/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Antibodies, Monoclonal, Humanized/adverse effects , Azetidines/therapeutic use , Azetidines/adverse effects , Purines/therapeutic use , Purines/adverse effects , Neck/pathology , Female , Facial Dermatoses/drug therapy , Facial Dermatoses/chemically induced , Male , Treatment Outcome , Drug Eruptions/etiology , Drug Eruptions/drug therapy , Middle Aged
3.
Acta Med Port
; 37(3): 229-230, 2024 Mar 01.
Article
Pt
| MEDLINE
| ID: mdl-38345386